We are live on ! Find out more
PM

Ponoi Management Portfolio holdings

AUM $73.2M
1-Year Est. Return 23.44%
This Fund
S&P 500
This Quarter Est. Return
-17.63%
1 Year Est. Return
-23.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$63.3M
AUM Growth
-$13.7M
Cap. Flow
+$11
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

1
NRIX icon
Nurix Therapeutics
NRIX
+$11

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPT
1
DELISTED
RAPT Therapeutics
RAPT
$29.2M 46.09%
199,927
– –
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$16.7M 26.29%
1,298,908
– –
RVMD icon
3
Revolution Medicines
RVMD
$39.7B
$13.4M 21.08%
685,011
– –
NRIX icon
4
Nurix Therapeutics
NRIX
$2.39B
$4.14M 6.54%
327,123
+1
+0% +$11

Similar funds

RC
Ronit Capital London, United Kingdom $73.5M AUM 13.35% 1-Year Est. Return
WM
Westpark Management Plano, Texas $71.7M AUM 22.07% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
SMC
S. Muoio & Co New York $75.7M AUM 42.51% 1-Year Est. Return
CCM
Composite Capital Management Hong Kong $70.1M AUM 79.53% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return